Evidence map›Paper›PMID 33307134›Full record

ReviewDiabetes research and clinical practice2021

COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis.

Mark Thomaz Ugliara Barone, Belinda Ngongo, Simone Bega Harnik, Lucas Xavier de Oliveira, Dániel Végh, Patrícia Vieira de Luca, Hermelinda Cordeiro Pedrosa, Franco Giraudo, Roque Cardona-Hernandez, Nayanjeet Chaudhury and 1 more

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diabetes research and clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 7 countries.

Mark Thomaz Ugliara BaroneInternational Diabetes Federation (IDF), 166 Chaussee de La Hulpe B-1170 Brussels, Belgium; ADJ Diabetes Brasil (ADJ), Rua Padre Antônio Tomás, 213, Zip Code 05003-010, Água Branca, São Paulo, SP, Brazil; Fórum Intersetorial para Combate às DCNTs no Brasil (ForumDCNTs), Rua Padre Antônio Tomás, 213, Zip Code 05003-010, Água Branca, São Paulo, SP, Brazil; Sociedade Brasileira de Diabetes (SBD), Rua Afonso Braz 579, Salas 72/74, Vila Nova Conceição, Zip Code 04511-011, São Paulo, SP, Brazil. Electronic address: mark.barone@alumni.usp.br.
Belinda NgongoPan African Women in Health (PAWH), P.O. Box 95535, Grant Park, 2051, South Africa.
Simone Bega HarnikUniversidade de São Paulo (USP), Instituto de Matemática e Estatística, Departamento de Estatística, Rua do Matão 1010, Cidade Universitária, Zip Code 05508-090, São Paulo, SP, Brazil.
Lucas Xavier de OliveiraInternational Diabetes Federation (IDF), 166 Chaussee de La Hulpe B-1170 Brussels, Belgium; ADJ Diabetes Brasil (ADJ), Rua Padre Antônio Tomás, 213, Zip Code 05003-010, Água Branca, São Paulo, SP, Brazil; Liga de Enfermagem na Atenção ao Diabetes da Escola de Enfermagem da Universidade de São Paulo (LEAD-EE-USP), Av. Dr. Enéas Carvalho de Aguiar, 419, Zip Code 05403-000, Cerqueira César, São Paulo, SP, Brazil.
Dániel VéghInternational Diabetes Federation (IDF), 166 Chaussee de La Hulpe B-1170 Brussels, Belgium; Semmelweis University, Faculty of Dentistry, Department of Prosthodontics, Budapest, Hungary.
Patrícia Vieira de LucaFórum Intersetorial para Combate às DCNTs no Brasil (ForumDCNTs), Rua Padre Antônio Tomás, 213, Zip Code 05003-010, Água Branca, São Paulo, SP, Brazil; Associação Brasileira de Hipercolesterolemia Familiar (AHF), Rua Machado Bittencourt 190, Vila Clementino, Zip Code 04044-000, São Paulo, Brazil.
Hermelinda Cordeiro PedrosaSociedade Brasileira de Diabetes (SBD), Rua Afonso Braz 579, Salas 72/74, Vila Nova Conceição, Zip Code 04511-011, São Paulo, SP, Brazil; Research Centre, Endocrinology Unit, Regional Taguatinga Hospital, Secretary of Health, Brasilia, Federal District, Brazil.
Franco GiraudoInstitute Maternal and Child Research (IDIMI), School of Medicine, University of Chile, Santiago, Chile; Juvenile Diabetes Foundation of Chile (FDJ), Santiago, Chile.
Roque Cardona-HernandezHospital Sant Joan de Déu, Division of Pediatric Endocrinology, Barcelona, Spain.
Nayanjeet ChaudhuryPublic Health Institute, Oakland, CA, 555 12th Street, Suite 215, Oakland, CA, 94607; Ramaiah International Centre for Public Health Innovations, MS Ramaiah Nagar, MSRIT Post, Bangalore 560097, India.
Luiz Menna-BarretoGrupo Multidisciplinar de Desenvolvimento e Ritmos Biológicos (GMDRB), Escola de Artes, Ciências eHumanidades da Universidade de São Paulo (EACH-USP), Rua Arlindo Béttio, 1000 - Ermelino Matarazzo, São Paulo, SP 03828-000, Brazil.
International Diabetes Federation · BEUniversidade de São Paulo · BRHospital Sant Joan de Déu Barcelona · ESPublic Health Institute · USSemmelweis University · HUSociedade Brasileira de Diabetes · BRSouth African Association of Women Graduates · ZAUniversity of Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has gravely threatened high-risk populations, such as people with diabetes and other noncommunicable diseases, leading to disproportionate hospitalizations and deaths worldwide. It is well documented from previous outbreaks that diabetes increases the risk for poor outcomes due to SARS infection. In the present review, we bring evidence that the country and global level health crisis caused by COVID-19 could have been avoided or extremely minimized if measures to protect high-risk populations were implemented timely. In addition to general lockdowns, testing, tracing, isolation and hygiene measures, other specific interventions for diabetes and comorbidities management were shown crucial to allow the continuation of care services during the pandemic. These interventions included: teleconsultation, digital remote education andmonitoring, e-prescriptions, medicine delivery options, mobile clinics, and home point-of-care tests. In conclusion, we recommend prompt actions to protect the most vulnerable groups, valuing knowledge and experiences from previous outbreaks and lessons learned during the COVID-19 pandemic, in order to shield communities, health systems and the global economy.

Indexed as

Global HealthComorbidityCOVID-19HumansNoncommunicable DiseasesSARS-CoV-2CoronavirusCOVID-19DiabetesGlobal healthHealth systemsNoncommunicable diseases

Identifiers

PMID33307134
PMCPMC7724978
OpenAlexW3112542410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.